Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. It operates through the following segments: Banking and Diagnostics. The Banking segment comprises of cord blood, and cord lining and tissue services, which collects, processes and stores in laboratories. The Diagnostics segment consists of Metascreen, which is anon-invasive metabolic screening test designed for newborn babies, non-invasive prenatal testing and eyescreen, and a paediatric vision-screening services. The company was founded on May 2, 2001 and is headquartered in Singapore.